A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)
Public ClinicalTrials.gov record NCT05420961. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-Experienced Adults 50 Years of Age or Older
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This a study of V116 in adults ≥50 years of age who previously received a pneumococcal vaccination ≥1 year before enrollment. The primary objectives of this study are to evaluate the safety, tolerability, and immunogenicity of V116.
Study identification
- NCT ID
- NCT05420961
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 717 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 11, 2022
- Primary completion
- May 15, 2023
- Completion
- May 15, 2023
- Last update posted
- Oct 25, 2024
2022 – 2023
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Central Research Associates ( Site 0024) | Birmingham | Alabama | 35205 | — |
| Lenzmeier Family Medicine/CCT Research ( Site 0008) | Glendale | Arizona | 85308 | — |
| Fiel Family and Sports Medicine, PC/CCT Research ( Site 0006) | Tempe | Arizona | 85283 | — |
| Southland Clinical Research Center ( Site 0026) | Fountain Valley | California | 92708 | — |
| Diablo Clinical Research, Inc. ( Site 0019) | Walnut Creek | California | 94598 | — |
| Alliance for Multispecialty Research, LLC ( Site 0020) | Coral Gables | Florida | 33134 | — |
| Indago Research & Health Center, Inc ( Site 0005) | Hialeah | Florida | 33012 | — |
| Advanced Medical Research Institute ( Site 0018) | Miami | Florida | 33174 | — |
| Solaris Clinical Research ( Site 0025) | Meridian | Idaho | 83646 | — |
| Centennial Medical Group ( Site 0002) | Elkridge | Maryland | 21075 | — |
| Arcturus Healthcare , PLC, Troy Internal Medicine Research Division ( Site 0016) | Troy | Michigan | 48098 | — |
| Meridian Clinical Research, LLC ( Site 0009) | Norfolk | Nebraska | 68701 | — |
| Advanced Medical Research ( Site 0001) | Maumee | Ohio | 43537 | — |
| University of Texas Medical Branch-Sealy Institute for Vaccine Sciences Clinical Trials Program ( Si | Galveston | Texas | 77555 | — |
| Health Research of Hampton Roads, Inc. ( Site 0003) | Newport News | Virginia | 23606 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05420961, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 25, 2024 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05420961 live on ClinicalTrials.gov.